A Phase 1 study to evaluate the metabolism of [14C]PF-07104091 in healthy adult male participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518696-65-00

Acronym

C4161006

Enrollment

Registered

2025-07-22

Start date

2025-08-12

Completion date

2025-11-07

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

and triple negative breast cancer (TNBC), (HR) -positive human epidermal growth factor receptor 2 (HER2) -negative breast cancer (BC), non-small cell lung cancer (NSCLC), ovarian cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Age

18 Years to 64 Years

Countries

Netherlands

Outcome results